Celularity (CELUW) Consolidated Net Income (2019 - 2025)
Celularity (CELUW) reported Consolidated Net Income of -$24.4 million for Q4 2025, down 83.25% year-over-year from -$145.4 million in Q4 2024, and down 5.56% quarter-over-quarter from -$23.1 million in Q3 2025.
Celularity (CELUW) Consolidated Net Income (2019 - 2025) Analysis & Trends
Celularity (CELUW) has 7 years of Consolidated Net Income data on file, last reported at -$24.4 million in Q4 2025.
- Consolidated Net Income for Q4 2025 came in at -$24.4 million, down 83.25% year-over-year; the trailing twelve-month figure through Dec 2025 was -$91.7 million (down 58.42% YoY), and the FY2025 annual result was -$91.7 million, down 58.43% from the prior year.
- Consolidated Net Income declined to -$24.4 million in Q4 2025 per CELUW's latest filing, from -$23.1 million in the prior quarter.
- Over five years, Consolidated Net Income peaked at $49.9 million in Q3 2021 and troughed at -$93.9 million in Q3 2023.
- A 5-year average of -$21.6 million and a median of -$20.9 million in 2024 frame the typical range for Consolidated Net Income.
- The sharpest annual moves came in 2022 and 2023: Consolidated Net Income jumped 704.8% in 2022, then tumbled 2056.16% in 2023.
- A 5-year view of Consolidated Net Income shows it stood at -$4.0 million in 2021, then jumped by 704.8% to $24.4 million in 2022, then slumped by 60.93% to $9.5 million in 2023, then slumped by 239.24% to -$13.3 million in 2024, then tumbled by 83.25% to -$24.4 million in 2025.
- Business Quant data shows CELUW's Consolidated Net Income at -$24.4 million in Q4 2025, -$23.1 million in Q3 2025, and -$24.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.80 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.40 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Celularity | - | - | -3.27 Mn | -24.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -24.36 Mn |
| Sep 30, 2025 | -23.08 Mn |
| Jun 30, 2025 | -24.52 Mn |
| Mar 31, 2025 | -19.75 Mn |
| Dec 31, 2024 | -13.29 Mn |
| Sep 30, 2024 | -16.10 Mn |
| Jun 30, 2024 | -6.49 Mn |
| Mar 31, 2024 | -22.01 Mn |
| Dec 31, 2023 | 9.55 Mn |
| Sep 30, 2023 | -93.88 Mn |
| Jun 30, 2023 | -47.95 Mn |
| Mar 31, 2023 | -64.02 Mn |
| Dec 31, 2022 | 24.43 Mn |
| Sep 30, 2022 | 4.80 Mn |
| Jun 30, 2022 | 47.83 Mn |
| Mar 31, 2022 | -62.87 Mn |
| Dec 31, 2021 | -4.04 Mn |
| Sep 30, 2021 | 49.94 Mn |
| Jun 30, 2021 | -64.52 Mn |
| Mar 31, 2021 | -81.50 Mn |